Glucagon receptor signalling – backwards and forwards

Tongzhi WuSchool of Medicine, The University of Adelaide, Adelaide, Australia;NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, AustraliaView further author information

Christopher K. RaynerSchool of Medicine, The University of Adelaide, Adelaide, Australia;NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, AustraliaView further author information

Chinmay S. MaratheSchool of Medicine, The University of Adelaide, Adelaide, Australia;NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, AustraliaView further author information

Karen L. JonesSchool of Medicine, The University of Adelaide, Adelaide, Australia;NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, AustraliaView further author information

Michael HorowitzSchool of Medicine, The University of Adelaide, Adelaide, Australia;NHMRC Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, AustraliaCorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Author contributions

T. Wu, C. K. Rayner, C. S. Marathe, K. L. Jones and M. Horowitz and were all involved in conception, design and writing of the manuscript. All authors have approved the publication of this final version of the manuscript.

Declaration of interest

T. Wu has received travel support from Novartis. C. K. Rayner has received research funding from AstraZeneca, Merck Sharp & Dohme, Eli Lilly, Novartis and Sanofi. K. L. Jones has received research funding from Sanofi, AstraZeneca and drug supplies from Merck Sharp & Dohme. MH has participated in advisory boards and/or symposia for Novo Nordisk, Sanofi, Novartis, Eli Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, and AstraZeneca and has received honoraria for this activity. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

Dr Tongzhi Wu's salary is funded by a Royal Adelaide Hospital Florey Fellowship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Glucagon receptor signalling – backwards and forwards

Information for

Open access

Opportunities

Help and information

Glucagon receptor signalling – backwards and forwards

Author contributions

Declaration of interest

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature